"The way to win an atomic war is to make certain it never starts."Omar N. Bradley
|
| |
Cancer Preventive Measures
Cancer is a very deadly disease. This disease is one of the most deadly in terms of numbers killed year in and out. According to statistics one in three people will be affected by cancer. And one in four people will die of cancer. However cancer could be ...
How the season's of God and his Word helped me to Overcome Breast Cancer
Heal Cancer!!!!! Pray for a Breast Cancer Healing Prayer By Yvonne Lee Brown November 1, 2005 Overcoming Breast Cancer with the Season's of God How I accepted the feelings and emotions of having Breast Cancer My husband and I go to a wonderful church. ...
Why Switch to All Natural Cosmetics?
The human skin wraps and protects our bodies. It constitutes a living, dynamic tissue system. It has the remarkable ability to absorb applied products, partially or completely, into the bloodstream. In fact, up to 60% of the products we use on our ...
|
|
|
| |
How much chemotherapy does an obese woman need? Typically an obese woman with breast cancer would receive reduced doses of chemotherapy as they battle breast cancer. Back in June of 2005, a study published in the Archives of Internal Medicine concluded that obese women should receive chemotherapy based on actual women, and not in reduced amounts as the standard practice.
And now again a study presented in the August 2005 edition of Lancet claims that doctors should not reduce chemotherapy doses for obese women when no receptors for the hormone oestrogen have been found on the breast cancer cells. This type of cancer is called oestrogen-receptor negative.
Clinicians often reduce chemotherapy doses for obese patients because of worries about how the treatment may react with the patient and affect their overall health.
According to the study's director Marco Colleoni of the European Institute of Oncology, Italy, and his colleagues, reducing the first course of chemotherapy for obese patients with oestrogen-receptor negative breast cancer proves "detrimental".
Colleoni and his team looked at the relation between body-mass index (BMI), chemotherapy dose reduction, oestrogen receptor expression, and outcome for pre-menopausal women with breast cancer by examining data from four randomized trials.
They found that 97 out of 249 obese patients received less than 85% of protocol specified dose during the first course of chemotherapy compared with patients with normal and intermediate BMI.
Obese patients with oestrogen-receptor negative disease that received 85% or more of the first protocol specified dose had significantly better disease-free survival and overall survival than those who received less than 85% of the normally recommended dosage.
Yet, obese patients with oestrogen-receptor positive breast cancer who had reduced doses of chemotherapy did not have a significant difference in their outcome compared with those given the recommended chemotherapy doses.
And contrary to popular practice, the researchers also noticed that obese patients initially treated with protocol doses of chemotherapy did not have more toxicity than patients who received reduced doses.
Dr Marco Colleoni concluded that, "Our findings suggest that for women with ER-absent or ER-low tumours, reduction in chemotherapy dose should be avoided."
The message for obese women coping with cancer is to be aware of your risks and rights. Ask your doctor will she recommend lower doses of chemotherapy for you based on your weight and ask why.
Resource: Lancet, Archives of Internal Medicine
About the Author
Health author and Stanford University graduate Naweko San-Joyz lovingly writes from her home in San Diego. Her works include Acne Messages: Crack the Code of Your Zits and Say Goodbye to Acne (ISBN: 0974912204) and Skinny Fat Chicks, Why We're Still Not Getting This Dieting Thing (ISBN: 0974912212). http://www.Noixia.com>http://www.Noixia.com
|
|
|
|
|
|
 Family history can trump breast cancer gene test - Atlanta Journal Constitution
If breast cancer runs in the family, women can be at high risk even if they test free of the disease’s most common gene mutations, sobering new research shows. The genes BRCA1 and BRCA2 are linked with particularly aggressive hereditary breast ...
Exercise, calorie restricted diet ”lowers postmenopausal women ... - Thaindian.com
Washington, Nov 19 (ANI): Regular exercise and reduced-calorie diet can significantly cut breast cancer risk in postmenopausal women, suggests a new study. The research team from University of Texas at Austin have identified pathways by which calorie ...
Awareness, education vital to breast cancer detection - Arlington Heights Daily Herald
As the Executive Director of Breast Cancer Network of Strength Illinois, formerly Y-ME National Breast Cancer Organization, Illinois Affiliate, I would like to thank the Daily Herald for their great work in raising breast cancer awareness year after ...
Foreign students don bras for cancer awareness - Local
Inspired by an article in The Local, a group of foreign students in Linköping recently met up for a photo shoot to raise awareness about breast cancer. Shakila Rainbow-Rossi explains : To support this October’s Rosabandet Breast Cancer Awareness ...
Cancer Drug Ups Risk of Clots in Veins - Atlanta Journal Constitution
TUESDAY, Nov. 18 (HealthDay News) -- The widely used cancer drug Avastin appears to be associated with a greater risk of developing blood clots in the veins of patients with a variety of cancers. This risk lengthens an already long list of severe ...
|
